Floatz logo

Therapeutic Asset Ratings

119 results matching 1 filter

133,990 assets · 8,802 sponsors · 3,128 indications
Methodology v0.2
AssetSponsorPhaseRating
Absk021
Neoplasms
Abbisko Therapeutics Co, LtdP1C (37)
Ami-Hc
Neoplasms
Janssen Research & Development, LLCP1C (37)
Ami-Hc-Cf
Neoplasms
Janssen Research & Development, LLCP1C (37)
Ami-Lc
Neoplasms
Janssen Research & Development, LLCP1C (37)
Ami-Lc-Md
Neoplasms
Janssen Research & Development, LLCP1C (37)
Ast-201
Neoplasms
Aptamer Sciences, Inc.P1C (37)
Atlcar.Cd30.Ccr4 Cells
Neoplasms
UNC Lineberger Comprehensive Cancer CenterP1C (37)
Atv-1601
Neoplasms
Atavistik Bio, IncP1C (37)
bi 765179
Neoplasms
Boehringer IngelheimP1C (37)
Blu-701
Neoplasms
Blueprint Medicines CorporationP1C (37)
cs231295
Neoplasms
Chipscreen Biosciences, Ltd.P1C (37)
G 207
Neoplasms
M.D. Anderson Cancer CenterP1C (37)
gsk3745417
Neoplasms
GlaxoSmithKlineP1C (37)
gsk5533524
Neoplasms
GlaxoSmithKlineP1C (37)
GSK5764227
Neoplasms
GlaxoSmithKlineP1C (37)
Immunoglobulin G4, anti-(human CD3 antigen) (recombinant human monoclonal JNJ-75348780 ?4-chain), disulfide with recombinant human monoclonal JNJ-75348780 ? chain, (229?126?),(232?129?)-bis(disulfide) with immunoglobulin, anti-(human sialic acid-binding Ig-like lectin 2) (recombinant human single-domain VHH fragment)
Neoplasms
Janssen Research & Development, LLCP1C (37)
Jnj-1761981
Neoplasms
Johnson & Johnson Enterprise Innovation Inc.P1C (37)
Jnj-54179060
Neoplasms
Janssen Research & Development, LLCP1C (37)
Jnj-64264681
Neoplasms
Janssen Research & Development, LLCP1C (37)
Jnj-74856665
Neoplasms
Janssen Research & Development, LLCP1C (37)
Jnj-80948543
Neoplasms
Janssen Research & Development, LLCP1C (37)
Jnj-87704916
Neoplasms
Johnson & Johnson Enterprise Innovation Inc.P1C (37)
Jnj-87801493
Neoplasms
Janssen Research & Development, LLCP1C (37)
Jnj-87890387
Neoplasms
Janssen Research & Development, LLCP1C (37)
jv-394
Neoplasms
M.D. Anderson Cancer CenterP1C (37)
Showing 76 to 100 of 119 assets
PreviousPage 4 of 5Next